Ex Vivo

Product hub: Drive your drug discovery with an enhanced live cell metabolic assay platform

13 April 2022 | By

Detect rapid, real-time changes in cellular bioenergetics with a platform optimised for pharma.

TCR therapy – an attractive alternative to CAR T

24 March 2020 | By Nikki Withers (Drug Target Review)

Chimeric antigen receptor (CAR) T-cell therapies have produced encouraging clinical outcomes, demonstrating their therapeutic potential in mitigating tumour development. However, another form of T-cell immunotherapy based on T-cell receptors (TCR) has also shown great potential in this field. Here, Nikki Withers speaks to Miguel Forte who elaborates on the process…

Brochure: Pioneering cell and gene therapy solutions from discovery to the clinic

11 March 2020 | By Bio-Techne

Your vision is to create revolutionary cell and gene therapies to treat life threatening diseases. Bio-Techne and its family of brands is on this journey with you.

Drug discovered for Postural Orthostatic Tachycardia Syndrome (POTS)

9 March 2020 | By Rachael Harper (Drug Target Review)

A novel therapy, tested ex vivo, has been successful at correcting the dysfunctional body mechanism in Postural Orthostatic Tachycardia Syndrome (POTS).

Stem cells that can grow new bone discovered by researchers

6 March 2020 | By Victoria Rees (Drug Target Review)

A new population of stem cells that can generate bone has been revealed by researchers, which they say could have implications in regenerative medicine.

Whitepaper: Immune Cell Isolation & Culture

22 July 2019 | By Bio-Techne

Immune cell isolation and culture are necessary for both basic research aimed at investigating the functions of different immune cell types, and for expanding specific immune cell populations for therapeutic purposes.

A high-throughput approach to developing T-cell immunotherapies

23 May 2019 | By Sartorius

Join us as we discuss the promises and pitfalls associated with developing individualised antigen-specific T-cell therapy products for clinical use. 

BIOSTAT^® RM TX and Flexsafe^® RM TX Bags

14 February 2019 | By Sartorius

The BIOSTAT® RM TX system consists of an automated control unit and a rocking platform, for gently agitating a single-use Flexsafe® RM bag...

Transforming translational research: CANscript^TM – A better predictive model for oncology

27 April 2018 | By Mitra Biotech

In this webinar, speaker Mark Paris, PhD discussed a recent study evaluating a cohort of HNSCC patient tumours treated with anti-PD1 using CANscript TM;. He also be reviewed the results of this study as a means of investigating predictors of clinical response and identifying mechanisms of resistance.

Mitra Biotech

Effective drug transfer tests look promising for placenta-on-a-chip technology

21 February 2018 | By Drug Target Review

Researchers in America have demonstrated the feasibility of their ‘placenta-on-a-chip’ platform in studying how drugs are transported across the human placental barrier.

Healing wounds with cell therapy

31 May 2017 | By Niamh Marriott (Drug Target Review)

An experimental treatment in mice allows the reprogramming of blood cells in order to promote the healing process of cutaneous wounds...

UK biotech Orchard Therapeutics opens US operations in California

6 October 2016 | By Niamh Louise Marriott, Digital Content Producer

Foster City will serve as headquarters for Orchard Therapeutics North America, and will provide the central base for laboratory operations associated...